| abstract |
The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts and / or esters thereof. The compound is used in diseases associated with 2,3-oxidosqualene-lanosterol cyclase such as hypercholesterolemia, hyperlipidemia, atherosclerosis, vascular disease, filamentous fungal disease, parasitic infections, cholelithiasis, tumors and / or hyperproliferative disorders Treatment and / or prevention, and / or treatment and / or prevention of impaired glucose tolerance and diabetes.n n n Formula In n n n n n n n Wheren n n U, Y, V, W, L, X, A 1 , A 2 , A 3 , A 4 , A 5 and A 6 are as defined in the specification and claims. |